Terms: = Germ cell tumor AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
342 results:
1. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
[TBL] [Abstract] [Full Text] [Related]
2. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid cell tumor.
Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL
Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952
[TBL] [Abstract] [Full Text] [Related]
3. Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework.
Wang J; Zhang C; Zhang L; Yao HJ; Liu X; Shi Y; Zhao J; Bo X; Chen H; Li L
Cancer Gene Ther; 2024 Mar; 31(3):439-453. PubMed ID: 38146007
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
Cockerell I; Christensen J; Hoei-Hansen CE; Holst L; Grenaa Frederiksen M; Issa-Epe AI; Nedregaard B; Solhoff R; Heimdal K; Johannessen Landmark C; Lund C; Nærland T
Orphanet J Rare Dis; 2023 Dec; 18(1):377. PubMed ID: 38042867
[TBL] [Abstract] [Full Text] [Related]
5. An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberous sclerosis complex patients.
Liu M; Ye J; You X
Childs Nerv Syst; 2024 Mar; 40(3):823-829. PubMed ID: 37906297
[TBL] [Abstract] [Full Text] [Related]
6. Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant cell Astrocytoma.
Gau SY; Chen SL; Chang CS; Tsao TF; Tsai JD
Int J Med Sci; 2023; 20(10):1358-1362. PubMed ID: 37786437
[No Abstract] [Full Text] [Related]
7. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
[TBL] [Abstract] [Full Text] [Related]
8. "Oncocytoid Renal cell Carcinomas After Neuroblastoma" Represent tsc -mutated Eosinophilic Solid and Cystic Renal cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
[TBL] [Abstract] [Full Text] [Related]
9.
Xie J; Yang MR; Hu X; Hong ZS; Bai YY; Sheng J; Tian Y; Shi CY
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511135
[TBL] [Abstract] [Full Text] [Related]
10. Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH; Kademane K; Chai Soon Hou S; Jocelyn TXY; Zabidi-Hussin Z
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011272. PubMed ID: 37432030
[TBL] [Abstract] [Full Text] [Related]
11. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
12. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
Werle SD; Ikonomi N; Lausser L; Kestler AMTU; Weidner FM; Schwab JD; Maier J; Buchholz M; Gress TM; Kestler AMR; Kestler HA
NPJ Syst Biol Appl; 2023 Jun; 9(1):22. PubMed ID: 37270586
[TBL] [Abstract] [Full Text] [Related]
13. A Comparison of Clinical Outcomes for Subependymal Giant cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.
Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS
Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001
[TBL] [Abstract] [Full Text] [Related]
14. A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa.
Anderson WJ; Dong F; Fletcher CDM; Hirsch MS; Nucci MR
Am J Surg Pathol; 2023 May; 47(5):535-546. PubMed ID: 36856023
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel cell Polyomavirus-Negative Merkel cell Carcinomas and Neuroendocrine Carcinomas.
Hartsough E; Mino-Kenudson M; Lennerz JK; Dias-Santagata D; Hoang MP
Am J Clin Pathol; 2023 Apr; 159(4):395-406. PubMed ID: 36812363
[TBL] [Abstract] [Full Text] [Related]
16. Recent management trends of subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Shah Z; Tameezuddin A; Saeed Baqai MW; Shami MS
J Pak Med Assoc; 2023 Feb; 73(2):430-432. PubMed ID: 36800747
[TBL] [Abstract] [Full Text] [Related]
17. TZD-Based Hybrid Molecules Act as Dual Anti-
Dzitko K; Kaproń B; Paneth A; Bekier A; Plech T; Paneth P; Trotsko N
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768392
[TBL] [Abstract] [Full Text] [Related]
18. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
[TBL] [Abstract] [Full Text] [Related]
19. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
Capper D; Reifenberger G; French PJ; Schweizer L; Weller M; Touat M; Niclou SP; Euskirchen P; Haberler C; Hegi ME; Brandner S; Le Rhun E; Rudà R; Sanson M; Tabatabai G; Sahm F; Wen PY; Wesseling P; Preusser M; van den Bent MJ
Neuro Oncol; 2023 May; 25(5):813-826. PubMed ID: 36632791
[TBL] [Abstract] [Full Text] [Related]
20. Genomic Alterations and tumor Mutation Burden in Merkel cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract] [Full Text] [Related]
[Next]
